Literature DB >> 18202126

Plasma adiponectin complexes have distinct biochemical characteristics.

Todd Schraw1, Zhao V Wang, Nils Halberg, Meredith Hawkins, Philipp E Scherer.   

Abstract

Adipocytes release the secretory protein adiponectin in a number of different higher-order complexes. Once synthesized and assembled in the secretory pathway of the adipocyte, these complexes circulate as biochemically distinct and stable entities with little evidence of interchange between the different forms that include a high-molecular-weight (HMW) species, a hexamer (low-molecular-weight form), and a trimeric form of the complexes. Here, we validate a high-resolution gel filtration method that reproducibly separates the three complexes in recombinant adiponectin and adiponectin from human and murine samples. We demonstrate that the HMW form is prominently reduced in male vs. female subjects and in obese, insulin-resistant vs. lean, insulin-sensitive individuals. A direct comparison of human and mouse adiponectin demonstrates that the trimer is generally more abundant in human serum. Furthermore, when the production of adiponectin is reduced, either by obesity or in mice carrying only a single functional allele of the adiponectin locus, then the amount of the HMW form is selectively reduced in circulation. The complex distribution of adiponectin can be regulated in several ways. Both mouse and human HMW adiponectin are very stable under basic conditions but are exquisitely labile under acidic conditions below pH 7. Murine and human adiponectin HMW forms also display differential susceptibility to the presence of calcium in the buffer. A mutant form of adiponectin unable to bind calcium is less susceptible to changes in calcium concentrations. However, the lack of calcium binding results in a destabilization of the structure. Disulfide bond formation (at position C39) is also important for complex formation. A mutant form of adiponectin lacking C39 prominently forms HMW and trimer but not the low-molecular-weight form. Injection of adiponectin with a fluorescent label reveals that over time, the various complexes do not interconvert in vivo. The stability of adiponectin complexes highlights that the production and secretion of these forms from fat cells has a major influence on the circulating levels of each complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202126      PMCID: PMC2329278          DOI: 10.1210/en.2007-1561

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

Authors:  A G Comuzzie; T Funahashi; G Sonnenberg; L J Martin; H J Jacob; A E Black; D Maas; M Takahashi; S Kihara; S Tanaka; Y Matsuzawa; J Blangero; D Cohen; A Kissebah
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

Authors:  N Maeda; M Takahashi; T Funahashi; S Kihara; H Nishizawa; K Kishida; H Nagaretani; M Matsuda; R Komuro; N Ouchi; H Kuriyama; K Hotta; T Nakamura; I Shimomura; Y Matsuzawa
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

3.  Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.

Authors:  Ken Kishida; Hiroyuki Nagaretani; Hidehiko Kondo; Hideki Kobayashi; Sachiyo Tanaka; Norikazu Maeda; Azumi Nagasawa; Toshiyuki Hibuse; Koji Ohashi; Masahiro Kumada; Hitoshi Nishizawa; Yoshihisa Okamoto; Noriyuki Ouchi; Kazuhisa Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  2003-06-20       Impact factor: 3.575

4.  Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.

Authors:  Utpal B Pajvani; Xueliang Du; Terry P Combs; Anders H Berg; Michael W Rajala; Therese Schulthess; Jürgen Engel; Michael Brownlee; Philipp E Scherer
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

5.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.

Authors:  Terry P Combs; Anders H Berg; Michael W Rajala; Simon Klebanov; Puneeth Iyengar; José C Jimenez-Chillaron; Mary Elizabeth Patti; Sabra L Klein; Robert S Weinstein; Philipp E Scherer
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

6.  Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects.

Authors:  Rita Basu; Utpal B Pajvani; Robert A Rizza; Philipp E Scherer
Journal:  Diabetes       Date:  2007-05-18       Impact factor: 9.461

7.  Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Authors:  Utpal B Pajvani; Meredith Hawkins; Terry P Combs; Michael W Rajala; Tom Doebber; Joel P Berger; John A Wagner; Margaret Wu; Annemie Knopps; Anny H Xiang; Kristina M Utzschneider; Steven E Kahn; Jerrold M Olefsky; Thomas A Buchanan; Philipp E Scherer
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

8.  Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Authors:  Julia Tonelli; Weijie Li; Preeti Kishore; Utpal B Pajvani; Elize Kwon; Charles Weaver; Philipp E Scherer; Meredith Hawkins
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

9.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

10.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more
  73 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Maternal overweight programs insulin and adiponectin signaling in the offspring.

Authors:  Kartik Shankar; Ping Kang; Amanda Harrell; Ying Zhong; John C Marecki; Martin J J Ronis; Thomas M Badger
Journal:  Endocrinology       Date:  2010-04-06       Impact factor: 4.736

3.  High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.

Authors:  Alexandra D Ogorodnikova; Sylvia Wassertheil-Smoller; Peter Mancuso; MaryFran R Sowers; Swapnil N Rajpathak; Matthew A Allison; Alison E Baird; Beatriz Rodriguez; Rachel P Wildman
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

Review 4.  Protective vascular and myocardial effects of adiponectin.

Authors:  Barry J Goldstein; Rosario G Scalia; Xin L Ma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-25

5.  DsbA-L is a versatile player in adiponectin secretion.

Authors:  Zhao V Wang; Philipp E Scherer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

Review 6.  Assembly of adiponectin oligomers.

Authors:  Tsu-Shuen Tsao
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

7.  Effects of training and detraining on adiponectin plasma concentration and muscle sensitivity in lean and overweight men.

Authors:  Caroline Gastebois; Clément Villars; Jocelyne Drai; Emmanuelle Canet-Soulas; Stéphane Blanc; Audrey Bergouignan; Etienne Lefai; Chantal Simon
Journal:  Eur J Appl Physiol       Date:  2016-09-08       Impact factor: 3.078

Review 8.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

9.  Unique profile of chicken adiponectin, a predominantly heavy molecular weight multimer, and relationship to visceral adiposity.

Authors:  Gilbert L Hendricks; Jill A Hadley; Susan M Krzysik-Walker; K Sandeep Prabhu; Regina Vasilatos-Younken; Ramesh Ramachandran
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

10.  Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans.

Authors:  Cristina Lara-Castro; Erin C Doud; Patrick C Tapia; Andres J Munoz; Jose R Fernandez; Gary R Hunter; Barbara A Gower; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2008-09-25       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.